Peregrine Asset Advisers Inc. Takes Position in iShares Biotechnology ETF (NASDAQ:IBB)
Peregrine Asset Advisers Inc. bought a new stake in shares of iShares Biotechnology ETF (NASDAQ:IBB – Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund bought 3,245 shares of the financial services provider’s stock, valued at approximately $397,000. A number […]